Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (2134)
  2. Journal Article (1757)
  3. Review (262)
  4. Editorial (133)
  5. Research Letter (85)
  6. Correspondence (45)
  7. Book Section (31)
  8. Guidelines (25)
  9. Miscellaneous (13)
  10. Conference Paper (8)
Groups
  1. Department of Medicine (4174)
  2. Weinberg Fellows (2757)
  3. Hematologic Malignancies, Division of (2493)
  4. Solid Tumor Oncology Division (2423)
  5. Center for Hematologic Malignancies (1945)
  6. GSK Faculty (1879)

More Groups

People
  1. Sergio Giralt (433)
  2. Michael Scordo (389)
  3. Gunjan Shah (348)
  4. Miguel-Angel Perales (338)
  5. Sean Devlin (289)
  6. Marcel Van Den Brink (263)

More People

Years
  1. 2025 (345)
  2. 2024 (636)
  3. 2023 (600)
  4. 2022 (628)
  5. 2021 (503)
  6. 2020 (496)

More Years

Publications
  1. Blood (713)
  2. Journal of Clinical Oncology (685)
  3. Annals of Oncology (133)
  4. Clinical Cancer Research (131)
  5. Cancer Research (126)
  6. Biology of Blood and Marrow Transplantation (124)

More Publications

Publishers
  1. American Society of Hematology (806)
  2. American Society of Clinical Oncology (774)
  3. Elsevier Inc. (544)
  4. Nature Publishing Group (358)
  5. American Association for Cancer Research (352)
  6. Oxford University Press (211)

More Publishers

Results (4493)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Temozolomide in grade 3 neuroendocrine neoplasms (G3 NENs): A multicentre retrospective review
    Meeting Abstract

    Chan, D.; Chan, J.; Halfdanarson, T.; Kunz, P.; McGarrah, P.; Raj, N.; Reidy-Lagunes, D.; Thawer, A.; Whitman, J.; Wu, Y. L.; more...
    Neuroendocrinology (2019)

    Fulltext@MSK | Save
  • RAS mutations confer an increased risk for relapse in patients with AML receiving induction chemotherapy
    Meeting Abstract

    Ball, B.; Goldberg, A.; Tallman, M.; Stein, E.
    Annals of Hematology (2019)

    Fulltext@MSK | Save
  • Expanding therapeutic opportunities for hematopoietic stem cell transplantation: T cell depletion as a model for the targeted allograft
    Review

    Cho, C.; Perales, M. A.
    Annual Review of Medicine (2019)

    Fulltext@MSK | Save
  • Genetic and epigenetic determinants of AML pathogenesis
    Review

    Cai, S. F.; Levine, R. L.
    Seminars in Hematology (2019)

    Fulltext@MSK | Save
  • Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia
    Journal Article

    King, A. C.; Pappacena, J. J.; Tallman, M. S.; Park, J. H.; Geyer, M. B.
    Leukemia Research (2019)

    Fulltext@MSK | Save
  • Genome-wide screening for enteric colonization factors in carbapenem-resistant ST258 Klebsiella pneumoniae
    Journal Article

    Jung, H. J.; Littmann, E. R.; Seok, R.; Leiner, I. M.; Taur, Y.; Peled, J.; van den Brink, M.; Ling, L.; Chen, L.; Kreiswirth, B. N.; more...
    mBio (2019)

    Fulltext@MSK | Save
  • Female representation among US National Comprehensive Cancer Network guideline panel members
    Editorial

    Green, A. K.; Barrow, B.; Bach, P. B.
    Lancet Oncology (2019)

    Fulltext@MSK | Save
  • A protean protein
    Journal Article

    Nawas, M. T.; Walker, E. J.; Richie, M. B.; White, A. A.; Hsu, G.
    Journal of Hospital Medicine (2019)

    Fulltext@MSK | Save
  • Next-generation sequencing–based assessment of JAK2, PD-L1, and PD-L2 copy number alterations at 9p24.1 in breast cancer: Potential implications for clinical management
    Journal Article

    Gupta, S.; Vanderbilt, C. M.; Cotzia, P.; Arias-Stella, J. A. 3rd; Chang, J. C.; Zehir, A.; Benayed, R.; Nafa, K.; Razavi, P.; Hyman, D. M.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • BRAF in the cross-hairs
    Review

    Geyer, M. B.; Abdel-Wahab, O.; Tallman, M. S.
    Expert Review of Hematology (2019)

    Fulltext@MSK | Save